Covid Pill Will Be Scarce as States Divvy Up the First Batch (1)

Just like Covid-19 testing sites and vaccines, Covid-19 treatment pills will be in short supply for months until production can increase.

The federal distribution to states will be based on population, and it will likely be up to doctors to prescribe Pfizer Inc.’s Paxlovid. The National Institutes of Health said it will release recommendations on how to allocate treatments.

New York will get only 3,180 courses of the newly cleared Covid-19 treatment pill for the state’s roughly 20 million residents when the U.S. government starts parceling them out on a per-capita basis in the coming week, according to a ...